The Oncology Institute Inc. (NASDAQ: TOI) is set to be added to the Russell 2000® and Russell 3000® Indexes following the 2025 Russell indexes annual reconstitution. This inclusion reflects TOI's growth and its innovative, value-based approach to cancer care. The change will be effective after the US market closes on June 27, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.